Loading clinical trials...
Loading clinical trials...
ChordArt System Study for the Treatment of Mitral Regurgitation Due to Leaflet Prolapse or Flail
The ChordArt System is a novel catheter based technology for mitral chordal replacement that enables controlled implantation of artificial mitral chords to treat mitral regurgitation with a minimally invasive approach. The implant is designed to allow transfemoral antegrade implantation.
ChordArt utilizes a minimally invasive catheter based approach by which multiple artificial chordae are precisely positioned into the papillary muscle and then secured to the pathological leaflet.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Vilnius University Hospital Santariskiu Klinikos
Vilnius, Lithuania
Start Date
March 21, 2018
Primary Completion Date
September 10, 2023
Completion Date
December 1, 2023
Last Updated
July 12, 2022
5
ACTUAL participants
ChordArt System
DEVICE
Lead Sponsor
CoreMedic GmbH
Collaborators
NCT07450911
NCT05927441
NCT03142152
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions